i3 - January/February 2017 - 71

Quell by NeuroMetrix
Quell® Wearable Pain Relief
Technologyâ„¢ is designed
for millions of people suffering from chronic pain. The
advanced wearable device is lightweight and can be worn
during the day while active, and at night while sleeping.
It has been cleared by the FDA for treatment of chronic
pain without a prescription. In a recent study, 81 percent of
Quell users reported an improvement in their chronic pain.
Quell users can start, stop and adjust therapy discreetly via
the optional Quell Relief app. Quell also offers advanced
sleep tracking that provides feedback on eight important
dimensions of sleep. Quell was the winner of the 2016
SXSW (South by Southwest) Innovation Award for Best
Wearable Technology.

to attach to a mechanical watch dial. It is the easiest and
fastest way to turn a classic watch into a smartwatch. The
electronic design discretely contained in the CT BAND is
the sharpest equipment on the market and offers the widest range of features available equipped with physiological
and environmental sensors. It provides three main modes
depending on the desired use: sport, health or weather.
Notifications received on the smartphone are accessible
directly from the smart strap.

NeuroMetrix is a commercial stage, innovation-driven
healthcare company combining bioelectrical and digital
medicine to address chronic health conditions including
chronic pain, sleep disorders and diabetes.

RightEye, LLC
RightEye LLC uses eye tracking and
gaming to revolutionize vision performance and healthcare. By following a
science-based, metric-driven methodology, RightEye helps
providers assess concussions, Parkinsons', autism, reading,
vision, and performance. RightEye will be launching its
RightEye GeoPref Autism Test as well as numerous visual
performance training games at Unveiled. RightEye's
GeoPref Autism test is based on protocol developed by top
autism researcher, Dr. Karen Pierce, of UCSD.

ReliefBand Technologies
Reliefband Technologies will be unveiling
Reliefband 2.0, the most
advanced "Treatable" available for the drug free-treatment
of nausea associated with morning and all forms of motion
sickness including virtual motion sickness caused by the
use of VR headsets. Completely reimagined and designed
for highly susceptible and frequent suffers of nausea and
those needing immediate relief, Reliefband's patented,
FDA-cleared, technology uses accurately programmed
pulses with highly specific waveform, frequency and intensity to stimulate the median nerve on the underside of the
wrist. This precise activity uses the body's natural neural
pathways to block the waves of nausea produced by the
stomach. Through years of clinical research, the safe and
highly effective technology behind Reliefband has been
used by doctors and hospitals for the treatment of morning
sickness as well as post-operative nausea and sickness
caused by therapies such as chemotherapy for nearly 20
years.
Rifft
Many people prefer the look and
feel of a traditional watch, but
want to take advantage of new
functionalities that wearable
technology has made possible. CT
BAND is dedicated for this kind of
person.
CT BAND is the world's first smartwatch strap designed

All sensors, as well as a tactile navigation touchpad and
screen are embedded in less than 4mm thick (silicone) or
5mm thick (leather). This miniaturized system is unique
and protected by numerous patents.

ROLI
ROLI is a London-based music
technology behind two of the most
future-facing musical instruments
of the past decade: The Seaboard
RISE and now ROLI BLOCKS, which
launched in November 2016 and is in Apple Stores around
the world.
BLOCKS is a modular music creation system that opens
up the world of music-making to everyone whether they're
a beginner or a pro. Each individual Block is powerful,
letting people shape more than 100 sounds and add effects
through simple, easy-to-learn gestures on touch-responsive surfaces. The Blocks connect magnetically to create
customizable kits that suit any budget, skill level and musical style. Music-makers build their BLOCKS kits as their
skills and interests grow.
RZA, Grimes and Steve Aoki, are some of the artists who
love making music with the $179 Lightpad Block, the
central Block in the system. The Lightpad Block adapts the
touch-sensitive surface of the Seaboard RISE (CES 2016
Best of Innovation) to a much more affordable, accessible
music device.



i3 - January/February 2017

Table of Contents for the Digital Edition of i3 - January/February 2017

Contents
i3 - January/February 2017 - Cover1
i3 - January/February 2017 - Cover2
i3 - January/February 2017 - 1
i3 - January/February 2017 - Contents
i3 - January/February 2017 - 3
i3 - January/February 2017 - 4
i3 - January/February 2017 - 5
i3 - January/February 2017 - 6
i3 - January/February 2017 - 7
i3 - January/February 2017 - 8
i3 - January/February 2017 - 9
i3 - January/February 2017 - 10
i3 - January/February 2017 - 11
i3 - January/February 2017 - 12
i3 - January/February 2017 - 13
i3 - January/February 2017 - 14
i3 - January/February 2017 - 15
i3 - January/February 2017 - 16
i3 - January/February 2017 - 17
i3 - January/February 2017 - 18
i3 - January/February 2017 - 19
i3 - January/February 2017 - 20
i3 - January/February 2017 - 21
i3 - January/February 2017 - 22
i3 - January/February 2017 - 23
i3 - January/February 2017 - 24
i3 - January/February 2017 - 25
i3 - January/February 2017 - 26
i3 - January/February 2017 - 27
i3 - January/February 2017 - 28
i3 - January/February 2017 - 29
i3 - January/February 2017 - 30
i3 - January/February 2017 - 31
i3 - January/February 2017 - 32
i3 - January/February 2017 - 33
i3 - January/February 2017 - 34
i3 - January/February 2017 - 35
i3 - January/February 2017 - 36
i3 - January/February 2017 - 37
i3 - January/February 2017 - 38
i3 - January/February 2017 - 39
i3 - January/February 2017 - 40
i3 - January/February 2017 - 41
i3 - January/February 2017 - 42
i3 - January/February 2017 - 43
i3 - January/February 2017 - 44
i3 - January/February 2017 - 45
i3 - January/February 2017 - 46
i3 - January/February 2017 - 47
i3 - January/February 2017 - 48
i3 - January/February 2017 - 49
i3 - January/February 2017 - 50
i3 - January/February 2017 - 51
i3 - January/February 2017 - 52
i3 - January/February 2017 - 53
i3 - January/February 2017 - 54
i3 - January/February 2017 - 55
i3 - January/February 2017 - 56
i3 - January/February 2017 - 57
i3 - January/February 2017 - 58
i3 - January/February 2017 - 59
i3 - January/February 2017 - 60
i3 - January/February 2017 - 61
i3 - January/February 2017 - 62
i3 - January/February 2017 - 63
i3 - January/February 2017 - 64
i3 - January/February 2017 - 65
i3 - January/February 2017 - 66
i3 - January/February 2017 - 67
i3 - January/February 2017 - 68
i3 - January/February 2017 - 69
i3 - January/February 2017 - 70
i3 - January/February 2017 - 71
i3 - January/February 2017 - 72
i3 - January/February 2017 - 73
i3 - January/February 2017 - 74
i3 - January/February 2017 - 75
i3 - January/February 2017 - 76
i3 - January/February 2017 - 77
i3 - January/February 2017 - 78
i3 - January/February 2017 - 79
i3 - January/February 2017 - 80
i3 - January/February 2017 - 81
i3 - January/February 2017 - 82
i3 - January/February 2017 - 83
i3 - January/February 2017 - 84
i3 - January/February 2017 - 85
i3 - January/February 2017 - 86
i3 - January/February 2017 - 87
i3 - January/February 2017 - 88
i3 - January/February 2017 - 89
i3 - January/February 2017 - 90
i3 - January/February 2017 - 91
i3 - January/February 2017 - 92
i3 - January/February 2017 - 93
i3 - January/February 2017 - 94
i3 - January/February 2017 - 95
i3 - January/February 2017 - 96
i3 - January/February 2017 - 97
i3 - January/February 2017 - 98
i3 - January/February 2017 - 99
i3 - January/February 2017 - 100
i3 - January/February 2017 - 101
i3 - January/February 2017 - 102
i3 - January/February 2017 - 103
i3 - January/February 2017 - 104
i3 - January/February 2017 - 105
i3 - January/February 2017 - 106
i3 - January/February 2017 - Cover3
i3 - January/February 2017 - Cover4
https://www.nxtbook.com/nxtbooks/manifest/i3_20210304
https://www.nxtbook.com/nxtbooks/manifest/i3_20210102
https://www.nxtbook.com/nxtbooks/manifest/i3_20201112
https://www.nxtbook.com/nxtbooks/manifest/i3_20200910
https://www.nxtbook.com/nxtbooks/manifest/i3_20200708
https://www.nxtbook.com/nxtbooks/manifest/i3_20200506
https://www.nxtbook.com/nxtbooks/manifest/i3_20200304
https://www.nxtbook.com/nxtbooks/manifest/i3_20200102
https://www.nxtbook.com/nxtbooks/manifest/i3_20191112
https://www.nxtbook.com/nxtbooks/manifest/i3_20190910
https://www.nxtbook.com/nxtbooks/manifest/i3_20190708
https://www.nxtbook.com/nxtbooks/manifest/i3_20190506
https://www.nxtbook.com/nxtbooks/manifest/i3_20190304
https://www.nxtbook.com/nxtbooks/manifest/i3_20190102
https://www.nxtbook.com/nxtbooks/manifest/i3_20181112
https://www.nxtbook.com/nxtbooks/manifest/i3_20180910
https://www.nxtbook.com/nxtbooks/manifest/i3_20180708
https://www.nxtbook.com/nxtbooks/manifest/i3_20180506
https://www.nxtbook.com/nxtbooks/manifest/i3_20180304
https://www.nxtbook.com/nxtbooks/manifest/i3_20180102
https://www.nxtbook.com/nxtbooks/manifest/i3_20171112
https://www.nxtbook.com/nxtbooks/manifest/i3_20170910
https://www.nxtbook.com/nxtbooks/manifest/i3_20170708
https://www.nxtbook.com/nxtbooks/manifest/i3_20160102
https://www.nxtbook.com/nxtbooks/manifest/i3_20160304
https://www.nxtbook.com/nxtbooks/manifest/i3_20160506
https://www.nxtbook.com/nxtbooks/manifest/i3_20160708
https://www.nxtbook.com/nxtbooks/manifest/i3_20170506
https://www.nxtbook.com/nxtbooks/manifest/i3_20170304
https://www.nxtbook.com/nxtbooks/manifest/i3_20170102
https://www.nxtbook.com/nxtbooks/manifest/i3_20161112
https://www.nxtbook.com/nxtbooks/manifest/i3_20160910
https://www.nxtbookmedia.com